EBioMedicine (May 2020)
Corrigendum to ‘‘Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type’’ [EBioMedicine 51 (2020) 102526]
- Qi Cai,
- Alana Christie,
- Satwik Rajaram,
- Qinbo Zhou,
- Ellen Araj,
- Suneetha Chintalapati,
- Nirmish Singla,
- Jeffrey Cadeddu,
- Vitaly Margulis,
- Ivan Pedrosa,
- Dinesh Rakheja,
- Renee M. McKay,
- James Brugarolas,
- Payal Kapur
Affiliations
- Qi Cai
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Alana Christie
- Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Satwik Rajaram
- Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Qinbo Zhou
- Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Ellen Araj
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Suneetha Chintalapati
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Nirmish Singla
- Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Jeffrey Cadeddu
- Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Vitaly Margulis
- Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
- Ivan Pedrosa
- Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Dinesh Rakheja
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- Renee M. McKay
- Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States
- James Brugarolas
- Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Corresponding authors at: Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
- Payal Kapur
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Corresponding authors at: Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
- Journal volume & issue
-
Vol. 55
